QVU
1 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- High Throughput Dna Sequencing For Hereditary Cancer Predisposition Assessment Test System.
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.6095
- Medical specialty
- Pathology
- FDA definition
- A high throughput DNA sequencing for hereditary cancer predisposition assessment test system is a qualitative in vitro diagnostic (IVD) system intended for analysis of human DNA extracted from human specimens to detect germline mutations in a panel of targeted cancer related genes. It is intended to aid in hereditary cancer predisposition assessment by qualified health care professionals in accordance with professional guidelines. The device is not intended for screening, prenatal testing or as a stand-alone diagnostic test. The device is for prescription use only.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| Invitae Common Hereditary Cancers Panel (DEN210011) | Invitae Corporation | 2023-09-29 |
Track QVU automatically
Every clearance here is in the API, with alerts when new ones post.